|
|
|
|
|
|
Aurinia Pharm Ord (AUPH)
|
|
6.25 +0.15 (+2.46%)
|
6/28/2017 4:00pm
|
|
Open:
|
6.08
|
Pre. Close:
|
6.10
|
|
High:
|
6.34
|
Low:
|
6.06
|
|
Volume:
|
1,007,874
|
Market Cap:
|
520.45M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
6.41 - 6.46
|
6.46 - 6.57
|
|
Low:
|
5.82 - 5.85
|
5.85 - 5.92
|
|
Close:
|
6.1 - 6.19
|
6.19 - 6.39
|
|
|
|
|
|
|
Technical analysis (as of: 2017-06-28 4:33:29 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a SELL today, upgraded from strong sell. But this stock still is very strong for short side. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.
|
|
Target:
|
Six months: 7.74  One year: 8.39
|
|
Support:
|
Support1: 5.74 Support2: 4.78
|
|
Resistance:
|
Resistance1:
6.63 Resistance2: 7.18
|
|
Pivot:
|
6.26
|
|
Moving Averages:
|
MA(5): 6.37 MA(20): 6.26
MA(100): 6.32 MA(250): 4.27
|
|
MACD:
|
MACD(12,26):
-0.11 Signal(12,26,9): -0.15
|
|
%K %D:
|
%K(14,3): 39.46 %D(3): 52.08
|
|
RSI:
|
RSI(14): 45.80
|
|
52-Week:
|
High: 10.54
Low: 1.74 Change(%): 131.5
|
|
Average Vol(K):
|
3-Month: 3571
10-Days 1801
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.AUPH has closed above bottom band by 48.7%. Bollinger Bands are 53.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to AUPH's normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
Wed, 28 Jun 2017 19:18:45 GMT
These two stocks are dominating the market, As Expected: Aurinia ...
Wed, 28 Jun 2017 19:30:00 GMT
Aurinia Pharmaceuticals Inc (AUPH) Lowered to “Sell” at Zacks Investment Research
Thu, 01 Jun 2017 14:41:32 GMT
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Is A Discount Entry At Current Price
Fri, 16 Jun 2017 13:07:30 GMT
Ongoing Aurinia Pharmaceuticals Study Results Boost Shares Higher
Wed, 21 Jun 2017 10:07:30 GMT
Aurinia to Host Annual General Meeting of Shareholders and Webcast on June 21 ...
|
|
|
Financial Analysis
|
|
Growth
|
NA
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
NA
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
NA
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
